Publikation: Molecular Characterization of Preneoplastic Lesions Provides Insight on the Development of Renal Tumors
Dateien
Datum
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
URI (zitierfähiger Link)
DOI (zitierfähiger Link)
Internationale Patentnummer
Link zur Lizenz
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Publikationsstatus
Erschienen in
Zusammenfassung
Kidneys are the second most frequent site for chemically induced cancers in rats. However, there is still limited information on direct effects of carcinogens on pathways involved in the development of kidney tumors. Since transformed tumor cells have different characteristics than their cell of origin, it was hypothesized that healthy tissue and progressing stages of preneoplastic lesions are differentially influenced by chemical carcinogens. To elucidate this question, TSC2-/- Eker rats were gavaged with genotoxic aristolochic acid or nongenotoxic ochratoxin A for 3 and 6 months, respectively. Histopathology and cell proliferation analysis demonstrated a compound- and sex-specific onset of preneoplastic lesions. In contrast, comparable gene expression profiles of lasermicrodissected preneoplastic lesions from carcinogen- treated and control rats, including reduced expression of genes involved in carcinogen uptake and metabolism, point to a compound-independent lesion progression. Gene expression profiles and additional immunostaining suggested that clonal expansion of renal lesions appears primarily driven by disturbed mammalian target of rapamycin complex 1 and mammalian target of rapamycin complex 2 pathway regulation. Finally, prolonged carcinogen exposure resulted in only marginal gene expression changes in tubules with normal morphology, indicating that some tubules may have adapted to the treatment. Taken together, these findings indicate that the final outcome of in vivo carcinogenicity studies is primarily determined by time-restricted initial events, while lesion progression may be a compound-independent process, involving deregulated mTOR signaling in the Eker rat model.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
Schlagwörter
Konferenz
Rezension
Zitieren
ISO 690
STEMMER, Kerstin, Heidrun ELLINGER-ZIEGELBAUER, Hans-Jürgen AHR, Daniel R. DIETRICH, 2009. Molecular Characterization of Preneoplastic Lesions Provides Insight on the Development of Renal Tumors. In: The American Journal of Pathology. 2009, 175(4), pp. 1686-1698. ISSN 0002-9440. eISSN 1525-2191. Available under: doi: 10.2353/ajpath.2009.081071BibTex
@article{Stemmer2009Molec-6814, year={2009}, doi={10.2353/ajpath.2009.081071}, title={Molecular Characterization of Preneoplastic Lesions Provides Insight on the Development of Renal Tumors}, number={4}, volume={175}, issn={0002-9440}, journal={The American Journal of Pathology}, pages={1686--1698}, author={Stemmer, Kerstin and Ellinger-Ziegelbauer, Heidrun and Ahr, Hans-Jürgen and Dietrich, Daniel R.} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/6814"> <dc:creator>Ellinger-Ziegelbauer, Heidrun</dc:creator> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-24T17:29:22Z</dcterms:available> <dc:contributor>Ahr, Hans-Jürgen</dc:contributor> <dc:creator>Stemmer, Kerstin</dc:creator> <dcterms:issued>2009</dcterms:issued> <dcterms:abstract xml:lang="eng">Kidneys are the second most frequent site for chemically induced cancers in rats. However, there is still limited information on direct effects of carcinogens on pathways involved in the development of kidney tumors. Since transformed tumor cells have different characteristics than their cell of origin, it was hypothesized that healthy tissue and progressing stages of preneoplastic lesions are differentially influenced by chemical carcinogens. To elucidate this question, TSC2-/- Eker rats were gavaged with genotoxic aristolochic acid or nongenotoxic ochratoxin A for 3 and 6 months, respectively. Histopathology and cell proliferation analysis demonstrated a compound- and sex-specific onset of preneoplastic lesions. In contrast, comparable gene expression profiles of lasermicrodissected preneoplastic lesions from carcinogen- treated and control rats, including reduced expression of genes involved in carcinogen uptake and metabolism, point to a compound-independent lesion progression. Gene expression profiles and additional immunostaining suggested that clonal expansion of renal lesions appears primarily driven by disturbed mammalian target of rapamycin complex 1 and mammalian target of rapamycin complex 2 pathway regulation. Finally, prolonged carcinogen exposure resulted in only marginal gene expression changes in tubules with normal morphology, indicating that some tubules may have adapted to the treatment. Taken together, these findings indicate that the final outcome of in vivo carcinogenicity studies is primarily determined by time-restricted initial events, while lesion progression may be a compound-independent process, involving deregulated mTOR signaling in the Eker rat model.</dcterms:abstract> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:contributor>Dietrich, Daniel R.</dc:contributor> <dcterms:bibliographicCitation>First publ. in: The American Journal of Pathology 175 (2009), 4, pp. 1686-1698</dcterms:bibliographicCitation> <dc:contributor>Ellinger-Ziegelbauer, Heidrun</dc:contributor> <dcterms:title>Molecular Characterization of Preneoplastic Lesions Provides Insight on the Development of Renal Tumors</dcterms:title> <dc:language>eng</dc:language> <dc:creator>Dietrich, Daniel R.</dc:creator> <dc:creator>Ahr, Hans-Jürgen</dc:creator> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2011-03-24T17:29:22Z</dc:date> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dc:format>application/pdf</dc:format> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/> <dc:rights>terms-of-use</dc:rights> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/6814/1/Stemmer_2009_1.pdf"/> <dc:contributor>Stemmer, Kerstin</dc:contributor> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/6814/1/Stemmer_2009_1.pdf"/> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/6814"/> </rdf:Description> </rdf:RDF>